Increased CCL18 plasma levels are associated with neurodegenerative MRI outcomes in multiple sclerosis patients. uri icon

authors

  • Ziliotto, Nicole
  • Zivadinov, Robert
  • Ramanathan, Murali
  • Bernardi, Francesco
  • Dejan Jakimovski MD, PhD
  • Baroni, Marcello
  • Bergsland, Niels
  • Ramasamy, Deepa P
  • Weinstock-Guttman, Bianca
  • Zamboni, Paolo
  • Marchetti, Giovanna

publication date

  • January 1, 2018